QPS Expands Offerings With Robust Pharmacology Disease Models, Including MASH, Ulcerative Colitis, Wound Healing, and Psoriasis

Contributed by: Business Wire

Logo

Business Wire logo

Images

Charlene Chen, PhD, Deputy General Manager & Head of the Center of Toxicology and Preclinical Sciences (CTPS) at QPS Taiwan
Charlene Chen, PhD, Deputy General Manager & Head of the Center of Toxicology and Preclinical Sciences (CTPS) at QPS Taiwan
Business Wire embedded0

Tags

Health
Clinical Trials
Research
Pharmaceutical
Science
Biotechnology
pharmacology disease models